跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Authorized
STANDARD
VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION
VPI Pharmaceuticals Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
5ac5821aae93b1a1
Company
VPI Pharmaceuticals Inc
Type
Standard
Approval Details
Approval Id
5ac5821aae93b1a1
Drug Approval Canada Name
VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Product Name
VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Status
Approved
Status Date
2016-02-29
Din
02452553
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
08:12.16.16
Atc Original
J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR
Atc Name
j 01 cr 05
Aig Number
0225919005
Company Name
VPI Pharmaceuticals Inc
Company Address
16667 Hymus Boulevard, Kirkland, Quebec, Canada, H9H 4R9
Company Detail Path
/organization/vpi-pharmaceuticals-inc
Company Information
Pharmaceutical Company Name
VPI Pharmaceuticals Inc
Country Name
Canada
Province Name
Quebec
City Name
kirkland,quebec,country_ca
Address
16667 boul Hymus
Active Ingredients
PIPERACILLIN (PIPERACILLIN SODIUM)
3 G / VIAL
TAZOBACTAM (TAZOBACTAM SODIUM)
0.375 G / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
5ac5821aae93b1a1
Type
Standard
Back to Health Canada Approvals
